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Formation of human capillaries in vitro: The engineering of
prevascularized matrices
Abstract
Initial take, development, and function of transplanted engineered tissue substitutes are crucially
dependent on rapid and adequate blood perfusion. Therefore, the development of rapidly and efficiently
vascularized tissue grafts is vital for tissue engineering and regenerative medicine. Here we report on the
construction of a network of highly organotypic capillaries in engineered tissue substitutes. We
employed a three-dimensional culture system consisting of human microvascular endothelial cells.
These were reproducibly expanded at high purity and subsequently seeded into biodegradable,
fibrin-based hydrogels. The process of capillary formation in vitro followed the principles of both
angiogenesis and postnatal vasculogenesis and a distinct sequence of other developmental steps that
closely resemble embryonic neovascularization. Capillary lumen formation in vitro was initiated by the
deposition of a basement membrane and intensive pinocytosis, followed by the generation of
intracellular vacuoles, successive fusion of these vacuoles, and finally the formation of a long,
continuous lumen. After transplantation the vascular structures were stabilized by mural cells of the
recipient animal. Our findings suggest that the in vitro engineering of prevascularized matrices is within
reach.
Formation of Human Capillaries In Vitro:
The Engineering of Prevascularized Matrices
Irene Montan˜o, Ph.D., Clemens Schiestl, M.D., Jo¨rg Schneider, M.D., Luca Pontiggia, Ph.D.,
Joachim Luginbu¨hl, M.S., Thomas Biedermann, M.S., Sophie Bo¨ttcher-Haberzeth, M.D.,
Erik Braziulis, Ph.D., Martin Meuli, M.D., and Ernst Reichmann, Ph.D.
Initial take, development, and function of transplanted engineered tissue substitutes are crucially dependent on
rapid and adequate blood perfusion. Therefore, the development of rapidly and efficiently vascularized tissue
grafts is vital for tissue engineering and regenerative medicine. Here we report on the construction of a network
of highly organotypic capillaries in engineered tissue substitutes. We employed a three-dimensional culture
system consisting of human microvascular endothelial cells. These were reproducibly expanded at high purity
and subsequently seeded into biodegradable, fibrin-based hydrogels. The process of capillary formation in vitro
followed the principles of both angiogenesis and postnatal vasculogenesis and a distinct sequence of other
developmental steps that closely resemble embryonic neovascularization. Capillary lumen formation in vitrowas
initiated by the deposition of a basement membrane and intensive pinocytosis, followed by the generation of
intracellular vacuoles, successive fusion of these vacuoles, and finally the formation of a long, continuous lumen.
After transplantation the vascular structures were stabilized by mural cells of the recipient animal. Our findings
suggest that the in vitro engineering of prevascularized matrices is within reach.
Introduction
Without an adequate vascular (supply) system noteven plane tissues (such as skin), let alone more vo-
luminous tissues (such as muscle or parenchymous organs),
will survive and thrive after transplantation.1
It is well known, however, that full-thickness skin (1–3mm
thick) is rapidly perfused after transplantation.2–6 Young et al.
have described three mechanisms responsible for graft sur-
vival and the establishment of blood supply of human full-
thickness skin, which are as follows: (1) diffusion of nutrients
through the graft (imbibition), (2) neovascularization,7 and (3)
and inosculation. Diffusion through the dermis is just too
inefficient to allow survival of the epidermis. Neovascular-
ization (by angiogenesis and vasculogenesis) occurs with a
large delay and therefore is not the critical mechanism that
keeps a transplant alive early after transplantation. Inoscula-
tion is the formation of anastomoses between graft and re-
cipient vessels. As inosculation occurs rapidly, it guarantees
survival of the graft early after transplantation. Thus, rapid
inosculation of an in vitro prevascularized, autologous graft is
what we envision in this project.
Recent advances in understanding the process of blood
vessel development have offered important tools for thera-
peutic neovascularization. Basically three approaches have
been attempted for vascularization of bioengineered tissue:
(1) incorporation of soluble angiogenic factors, (2) gene trans-
fer approaches,8,9 and (3) seeding of endothelial cells onto or
into matrices and scaffolds.2,10–13 Of these, the latter one
turned out to be most promising. Numerous matrices and
scaffolds have been used to study vessel formation under
controlled conditions. However, the heterogeneity of the
conditions used makes it difficult to compare findings be-
tween different laboratories. Models of vasculogenesis and
angiogenesis vary in endothelial cell type, number of endo-
thelial cells, types and concentrations of matrix components,
composition of soluble factors, and the time period the cells
were exposed to these conditions. Hardly any of these assays
closely recapitulates the in vivo process, and only few models
were designed for clinical use. This is also reflected by the fact
that in most of these models, animal endothelial cells or hu-
man umbilical vein endothelial cells (HUVECs) were used.
Autologous HUVECs, however, are still rarely available in a
clinical setting.
We show here that the human dermis is a perfect source of
microvascular endothelial cells that can be expanded in a
reproducible manner in culture. Further we demonstrate that
vasculogenesis and angiogenesis can occur in vitro under
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appropriate conditions and that the construction of true
three-dimensional (3D) capillary networks, hence the in vitro
engineering of prevascularized interstitial matrices, is within
reach. In a second phase we transplanted these pre-
vascularized matrices onto the backs of immunoincompetent
rats (see also our recent work14) and showed that mural cells
recruited from the underlying recipient mesenchyme stabi-
lized the engineered vessels.
Materials and Methods
Isolation of microvascular endothelial cells
Human microvascular endothelial cells (HuMECs) were
isolated from human foreskins obtained from the University
Children’s Hospital of Zurich after routine circumcisions and
stored in Dulbecco’s modified Eagle’s medium (Invitrogen,
Basel, Switzerland) supplemented with 1.5 mL=mL genta-
mycin, 30 mL=mL PenStrep, and 1mL=mL fungizone. All pa-
tients (and=or their parents) gave their written consent for
this study in accordance with the Ethics Commission of the
Kanton Zurich (notification no. StV-12=06). Foreskins were
cut into approximately 1 cm2 pieces and incubated with
75U=mL collagenase type II (Worthington, Lakewood, NY)
at 378C for 1 h. HuMECs were harvested by scraping the
dermal side with the back of a scalpel blade. The cell sus-
pension was centrifuged at 170 g for 10min and the cell pellet
was resuspended in microvascular endothelial cell growth
medium-2 (EBM-2MV; Lonza, Basel, Switzerland) with
supplements (Lonza, CC-4147). HuMECs were grown on 1%
gelatine-coated culture dishes in 5% CO2 at 378C. The me-
dium was changed three times a week. The cells were used at
passage 1 in all experiments.
Preparation of prevascularized fibrin matrices
Fibrinogen from bovine plasma (Sigma-Aldrich, Buchs,
Switzerland) was used for the preparation of fibrin gels. Fi-
brinogen was reconstituted in NaCl according to the in-
structions of the provider to a final concentration of 7, 9, 10,
11, 13, and 15mg=mL. To 1mL of fibrinogen solution, 1104,
3104, 5104, 1105, 2105 cells and 22mL thrombin (Sigma-
Aldrich, 50U=mL) were added and seeded in an insert for
six-well plates. After clotting at room temperature, the
preparations were incubated at 378C for 1 h in a humidified
incubator containing 5% CO2 to ensure polymerization of
fibrin. At the end of the incubation period, EBM-2MV was
added to the upper and lower chambers, and gels were in-
cubated for 3 weeks until transplantation. To prepare ran-
domly distributed single Endothelial cells (ECs) in fibrin gels,
a single-cell suspension of 100,000 cells was submerged
within 1mL of a fibrin gel and this gel was transplanted right
away.
Preparation of collagen type I hydrogels
Collagen type I hydrogels at final concentrations of 2.5,
3.0, and 3.5mg=mL were prepared using collagen type I
(5mg=mL; Symatese, Chaponost, France). Polymerization of
the acidic soluble collagen was reached by adding reconsti-
tution solution that contained 6mg=mL NaOH. The culture
medium was added 30min after polymerization.
Lyophilized collagen ‘‘sponges’’ or artificial skin were
provided by (Matricel, Herzogerath, Germany), EMCM (The
Netherlands), Symatese, and (Integra Life Sciences, Geneva,
Switzerland).
Grafting to athymic rats
Animal studies were performed with the approval of the
Institutional Animal Care of the University of Zurich fol-
lowing the guidelines of the National Institutes of Health.
Immunoincompetent female Nu=Nu rats (Elevage Janvier)
were anaesthetized by inhalation of 5% isofluran (Baxter,
Volketswil, Switzerland) and narcosis maintained by inha-
lation of 2.5% isofluran via mask. Before the operation,
0.5mg=kg buprenorphin (Temgesic; Essex, Luzern, Swit-
zerland) for analgesia and retinol cream (Vitamin A
‘‘Blache’’; Bausch & Lomb, Berlin, Germany) for eye pro-
tection were applied. To prevent wound closure from the
side, a special polypropylene ring, 2.6 cm in diameter, was
designed in our laboratory. The rings were sutured to full-
thickness skin defects created on the back of the rats using
nonabsorbable polyester sutures (Ethibond; Ethicon, Nor-
derstedt, Germany).
Cultured fibrin gels (n¼ 5 per group) were placed into the
polypropylene rings and covered with a silicon foil (Silon-
SES; BMS) and polyurethane sponges (Ligasano; Ligamed,
adolzbufe, Germany). Controls with unorganized HuMECs
and empty gels were included.
Rats were sacrificed at 5 days and 2 weeks after surgery.
At sacrifice, dressings and sutures were removed and mul-
tiple graft biopsies were collected for different analyses.
Histological analyses
Skin equivalents were fixed in 4% neutral formalin and
embedded in paraffin according to the standard protocols.
The 6mm sections were cut and stained using Mayer’s
hematoxylin and eosin solution (both from Sigma-Aldrich).
Immunohistochemical analyses
Biopsies were embedded in Tissue Tek. Cryosections
(10mm)were fixed for 5min in acetone–methanol at208C and
blocked for 30min in 2% normal goat serum in phosphate-
buffered saline (PBS) before antibody incubation. The fol-
lowing primary antibodies were used: rabbit anti-human von
Willebrand factor (vWf) (DakoCytomation; 1:100, Baar,
Switzerland), monoclonal mouse anti-human CD31 (Dako-
Cytomation; 1:40), mouse anti-SMA (DakoCytomation;
1:100), rabbit anti-laminin 1þ 2 (Abcam, Cambridge, MA),
monoclonal mouse anti-human CD90 (Thy-1), and clone
AS02 (Dianova; 1:100, Hamburg, Germany). This antibody
reacts specifically with human CD90 (Thy-1), a glycosyl-
phosphatidyl-inositol (GPI)-anchored glycoprotein that is
expressed in various types of human fibroblasts (see Supple-
mental Fig. S1, available online at www.liebertonline.com=
ten). Secondary antibodies used were as follows: Fluorescein-
isothiocyanat (FITC)-conjugated polyclonal goat F(ab0)2
fragments directed to mouse immunoglobulins (DakoCyto-
mation), FITC-conjugated polyclonal swine F(ab0)2 frag-
ments directed to rabbit immunoglobulins (DakoCytomation),
Tetramethylrhodamine-5-isothiocyanat (TRITC)-conjugated
polyclonal rabbit directed to mouse immunoglobulins
(DakoCytomation), and FITC-conjugated polyclonal rabbit
directed to goat immunoglobulins (DakoCytomation). All
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antibodies were incubated at 378C for 1 h. Nuclei were
counterstained with Hoechst. All slides were mounted with
fluorescent mounting medium (DakoCytomation). For the
staining of the paraffin-embedded samples, antigen retrieval
was performed (Dako Target retrieval solution).
Specificity of human cell markers was confirmed by the
absence of any signal in untransplanted control animals. In
addition, omission of the first antibody was used as a neg-
ative control. Immunocytochemistry was also used to con-
firm the identity of HuMECs in culture using the monoclonal
antibody against the endothelial cell marker CD31.
In situ hybridization
DNA labeling with digoxigenin. Human genomic DNA of
a free volunteer was extracted with the QIAamp DNA Blood
Midi Kit (Qiagen, Basel, Switzerland). The polymerase chain
reaction (PCR) primers were positioned in the most con-
served areas of human Alu sequences and produced a PCR
product of 245 bp using the modified method of Just et al.15
Modifications were as follows. For PCRs, following primers
for Alu sequences were used:
Alu-sense: 50 ACG CCT GTA ATC CCA GCA CTT 30
Alu-antisense: 50 TCG CCC AGG CTG GAG TGCA 30
PCR was carried out under the following conditions: 948C
for 10min, 30(948C for 30 s, 588C for 45 s, 728C for 45 s) and
728C for 10min. PCR products were electrophoresed on a 2%
agarose gel and stained with ethidium bromide [1.5 mg=mL in
1tris-acetate-EDTA (TAE)]. DNA band of 245 bp was eluted
with the high pure PCR product purification kit (Roche, Basel,
Switzerland). The PCR product was digoxigenin (DIG) la-
beledwith the PCRDIG probe synthesis kit (Roche). This PCR
was performed with 50 ng eluted DNA by using the same
PCR protocol, as described above. The labeled probe was
purified by ethanol precipitation according to the protocol of
PCR DIG probe synthesis kit.
In situ hybridisierung (ISH) on paraffin sections. Paraffin
sections (5mm) were mounted on silane-coated slides (Sigma-
Aldrich) and dried overnight at 378C. Sections were depar-
affinized in xylene, rehydrated in a graded ethanol series,
and air dried. The protocol followed is based on the method
described by Just et al. with some modifications.15 After three
washes for 5min with PBS (0.1mM, pH 7.4), slides were
incubated with PBS containing 0.3% Triton X-100 for
10min. Slides were then incubated with tris-EDTA (TE)
buffer containing 2mg=mL proteinase K, for 25min at 378C
and rinsed again three times for 5min in TE buffer. To reduce
nonspecific background, slides were acetylated using TEA
buffer (0.1M triethanolamine, pH 8.0) containing 0.25% (v=v)
acetic anhydride (Sigma) twice for 5min. After prehybridi-
zation with hybridization buffer (50% formamide [Sigma-
Aldrich] in 5saline-sodium citrate (SSC), 0.1% sodium=
lauroylsarcosine [Sigma], 0.02% SDS [Sigma], 2% blocking
reagent [Roche]) for 150min at 858C, slides were incubated
with fresh hybridization buffer containing the denatured
DIG-labeled DNA probe (100 ng=mL) for further 2 h at 858C.
After that slides were immediately transferred to ice for
10min and then incubated overnight at 428C. Prehybridiza-
tion and hybridization steps were performed in a moist
chamber containing 50% formamide. After hybridization,
slides were briefly rinsed in 2SSC at room temperature and
three times in 0.1SSC for 15min at 428C. Observation of the
hybridized DNA probe was performed according to the
protocol of the DIG nucleic acid detection kit (Roche). The
slides were incubated with alkaline phosphatase–conjugated
antibody solution (1:2000 in blocking buffer [1% blocking
reagent; Roche] containing 0.1% Triton X-100) for 1 h, fol-
lowing four washes with maleic acid buffer (0.1M maleic
acid, 0.15M NaCl, pH 7.5) for 15min. Slides were equili-
brated for 5min in Tris buffer pH 9.5 (0.1M Tris, pH 9.5,
0.1M NaCl, 50mM MgCl2). The color development was
carried out with freshly prepared substrate solution (nitro-
blue tetrazolium salt and 5-bromo-4-chloro-3-indolyl phos-
phate (X phosphate) (Roche) in Tris buffer (pH 9.5). After 15
to 30min, the enzymatic reaction was terminated with stop
buffer (10mM Tris=HCl, pH 8.0, 1mM ethylenediaminete-
traacetic acid). Slides were washed three times for 15min
and incubated with phosphate-buffered Hoechst solution
(1mg=mL) for 15min. Finally, slides were rinsed three times
with PBS.
Transmission electron microscopy
The gels containing the vascular structures were fixed in
50mM sodium cacodylate buffer, pH 7.3, containing 2%
glutaraldehyde and 0.8% paraformaldehyde and postfixed
with 1% OsO4 in 50mM sodium cacodylate buffer, pH 7.3,
dehydrated in an ethanol series and embedded into epon
(Catalys). Ultrathin sections of 50 nm were contrasted with
uranyl acetate and lead citrate and studied with a CM 100
transmission electron microscope (Phillips, Zurich, Switzer-
land).
Light microscopy
Capillaries were viewed at distinct stages of graft forma-
tion and posttransplantation by both epi-illuminated ste-
reomicroscopy and inverse light microscopy.
Results
Vascular structures develop in a fibrin-based hydrogel
We prepared HuMECs from 32 different foreskins. The
foreskins were derived from children and young adults
ranging in age from newborn to 18 years old. There were two
foreskins from newborns. We consider the cells derived from
15, 17, and 18-year-old patients as adult cells. We have
shown in 23 distinct experiments that HuMECs isolated from
all categories of patients mentioned above can develop into
lumenized vascular structures within fibrin hydrogels. To
harvest maximal numbers of HuMECs at high purity, a novel
procedure was developed. With this method it became pos-
sible to rapidly isolate CD31 (PECAM1)-positive HuMECs
from human skin biopsies at about 98% purity (Fig. 1A and
Supplemental Fig. S1). Thus, an additional enrichment of
HuMECs by fluorescence-activated cell sorting (FACS) or
magnetic cell separation (MACS) was not necessary. Further,
we developed collagen and fibrin-based biodegradable ma-
trices to screen for optimal 3D organotypic structure forma-
tion. We tested fibrin hydrogels at concentrations of 7, 9, 10,
11, 13, and 15mg=mL. In addition, collagen hydrogels at final
concentrations of 2.5, 3.0, and 3.5mg=mL were examined.
Finally, collagen=fibrin composite hydrogels mixed at con-
centrations (fibrinþ collagen) of 7þ 3mg=mL, 9þ 3mg=mL,
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and 10þ 3mg=mL were investigated. Among the tested
matrices, only fibrin-based hydrogels at concentrations of 10
and 11mg=mL allowed the formation of true 3D and lume-
nized vascular structures. Other fibrin concentrations turned
out to be suboptimal, leading to short cords or irregular cell
aggregates that did not exhibit lumen formation and showed
only moderate branching (data not shown). Similarly, in
collagen hydrogels, HuMECs remained mostly as spherical
aggregates or as very short cords (data not shown). Under
these conditions neither branching nor lumen formation
was observed. In fibrin=collagen hybrid gels, few extended
and branching cords were observed. However, lumen for-
mation was not possible (data not shown). Thus, the in vitro
development of branching and lumenized vascular struc-
tures was only possible in a limited density of reconstituted
fibrin matrix.
All fibrin gels were initially 1mm thick. This matrix did
not shrink in vitro and could be conveniently handled during
surgical interventions (Fig. 1B). Moreover, the presence of
vascular structures had a clear effect on the stability of the
fibrin matrix. The preformed vascular structures clearly
contributed to the thickness and stability of the substitute.
Without vascular structures the gel had an increased fluidity,
which on the one hand increased its radius and on the other
hand decreased its thickness. (Fig. 1C, D) We did not observe
significant degradation of the fibrin gels in vitro because the
numbers of fibroblasts were low or zero.
The 3D distribution of HuMECs within the biodegradable
matrix, and hence its homogeneous population by vascular
structures, was achieved upon submerging the cells in the
rapidly polymerizing matrix. Rapid polymerization was
crucial, since it forced the HuMECs to stay firm in their
different planes and 3D positions. By this procedure their
sedimentation and accumulation in only one plane (two-
dimensional), that is on the underlying porous membrane,
was avoided. As a result HuMECs evenly distributed in
three dimensions developed into clusters of proliferating
endothelial cells. Importantly, within about 5 days these cells
gave rise to branching organotypic structures consisting of
single, elongated cells (Fig. 2A). Apparently a sufficient
number of precursor cells was present in our preparations of
dermal HuMECs to permit vasculogenesis in vitro. At about
FIG. 1. Highly enriched HuMECs submerged within a novel biodegradable matrix. (A) HuMECs derived from dermis
growing out from capillary fragments (arrows) on cell culture plastic. CD31 (PECAM) expression confirms the endothelial
origin of the cells (inset). (B) The fibrin-based matrix remains stable in size and pliability after vascular structures have
developed (3 weeks in culture). (C) Vascular structures thicken and stabilize the hydrogel. (D) The acellular hydrogel is
thinner and significantly less stable than the prevascularized gel. Scale bars in (A) 50 mm; (B) 1 cm; (C); and (D) 100 mm.
HuMEC, human microvascular endothelial cells. Color images available online at www.liebertonline.com=ten.
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FIG. 2. The distinct steps of capillary formation in vitro. (A) Single HuMECs assemble into faint branching cords 5 days after
submerging them into fibrin-based hydrogels of approximately 1mm thickness. (B) Vascular structures forming after 7 days
in culture. (C) Dependent on the number of initially plated cells, HuMECs develop into dense networks of branching solid
cords. Anastomoses are indicated by circles. (D) Histological analyses (HE staining) 10 days after plating reveal that the
developing structures comprise solid cords. Note the cytoplasmatic hematoxylin staining that indicates that no lumen has
formed yet. (E) Successively arranged vacuoles (arrows) undergo fusion to form increasing lumens in vascular structures. (F)
Three vacuole-forming HuMECs aligning in an overlapping fashion. Cell borders are indicated by dotted lines. All scale bars:
50 mm. HE, hematoxylin and eosin. Color images available online at www.liebertonline.com=ten.
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FIG. 3. Phase-contrast microscopy of branching, completely lumenized capillaries developing in hydrogels in vitro. (A)
Regularly alternating nuclei (white arrows) and the cytoplasm are closely associated with the plasma membrane. Black
arrows indicate the lumen. (B) The two branches of a capillary are indicated by white arrows. Black arrows indicate the
lumen. (C) Histological sections and HE staining reveal that almost all vascular structures exhibit a lumen 25 days after
plating. Black arrows indicate the lumen. Note that the lumen is free of hematoxylin staining. (D) A series of cross sections
through lumenized capillaries that have developed in fibrin hydrogels. Sections were counterstained with toluidine blue.
Scale bars in (A) and (B) 10mm, and in (C) and (D) 30mm. Color images available online at www.liebertonline.com=ten.
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7–10 days after cell plating, the vascular structures became
longer and stronger and developed into solid branching
cords (Fig. 2B). Dependent on the number of the initially
plated endothelial cells, the structures extended into real
networks. Here anastomoses were obvious (Fig. 2C, circles).
Histological analyses revealed that at this stage HuMECs
had arranged into a network of solid cords and lumen for-
mation was not detected in any of the structures (Fig. 2D).
The optimal cell number was 3104 cells per mL of gel. At
very high cell numbers (e.g., 2105 cells per mL), numerous
and very thin cords occurred (data not shown). These
structures obviously were in competition for growth factors
and nutrients, so that the development of normally sized
cords and a subsequent lumen formation was not possible.
At low cell concentrations (5000–10,000 cells=mL), some spot
wise, focal outgrowth of vascular structures occurred. In
these structures, large vacuoles were frequently detectable,
while formation of a continuous lumen was rare (data not
shown).
Vacuoles fuse to form a lumen
About 15 days after plating, rows of successively arranged
vacuoles became evident in most of the cords. In addition,
short stretches of fused vacuoles became visible representing
the first lumenized segments (Fig. 2E, arrows). The fusion
process did not occur synchronously throughout the vascular
structure but was rather initiated in certain spots within the
structure. However, lumen formation occurred in 70–80% of
the vascular structures in one gel. Figure 2F shows three
adjacent elongated cells overlapping at their ends. Phase-
contrast light microscopy revealed that some vacuoles within
one cell fused to form a larger vacuole. Light microscopy,
however, could not reveal whether lumen formation just oc-
curred in the cytoplasm of individual cells or whether the
lumen developed in the intercellular space. After about 20
days in culture, highly organotypic, branching capillaries had
developed with nuclei positioned at their faint cell mem-
branes (Figs. 3A–C). Finally, a network of branching and in-
terconnected capillaries had developed (Figs. 3B, C).
Although lumen formation was obvious by phase-contrast
microscopy, we performed histological analyses that revealed
the presence of a complete lumen in 70–80% of the structures
(Fig. 3C). Notably, no mural cells, such as pericytes and vas-
cular smooth muscle cells, were attached to the capillaries
(Fig. 3A–C). Lumen formation was also shown by a series of
cross sections through lumenized capillaries grown in fibrin
hydrogels (Fig. 3D). These findings indicate that a network of
simple human capillaries can be generated in vitro.
Transmission electron microscopy and
immunofluorescence data reveal that lumen
formation occurs according to the cord
hollowing mechanism of tubulogenesis
To gain additional insight into the mechanism of lumen
formation, electron microscopical analyses were performed.
In Figure 4A two elongated HuMECs after 2 days in a fibrin
gel are depicted. The optimal density of fibrin fibers that
ideally supports capillary formation is shown. A basement
membrane (BM) is not yet deposited. As HuMECs form
contacts and develop into branching cords (shown in Fig. 2),
they also start to interact with their extracellular environment.
Two important processes take place. First, a BM is produced
(black arrows in Fig. 4B, C). The deposition of a BM was
always detected in ECs that arranged into vascular structures
in fibrin hydrogels. The BM instructs the endothelial cells to
polarize, which is the establishment of a basolateral and an
apical (luminal) membrane domain. Apparently without
apical and basolateral polarization, no lumen formation is
possible. Second, extensive pinocytosis (cell drinking) is ob-
served in all samples investigated (Fig. 4B, C, white arrows).
Vesicles invaginating from the plasma membrane are taken
up by the cytoplasm, and obviously these vesicles are fusing
to form large intracellular vacuoles (Fig. 4C, filled gray
arrows). Deposition of BM components 15 days after plating
is confirmed by immunofluorescence employing laminin
1þ 2 and CD31 antibodies (Fig. 4D–G). All cells of the in vitro
engineered vascular structure are CD31 positive (Fig. 4E). The
nuclei of this structure are arranged around the lumen, as
revealed byHoechst staining (Fig. 4F). Themerger of the three
afore-mentioned immunostainings is shown in Figure 4G.
Figure 4H illustrates that the lumen develops in the intercel-
lular space, which is always free of matrix material. We con-
sider it likely that the intracellular vacuoles fuse with the
luminal (apical) membrane to increase the lumen. Hence, as
the lumen forms, the participating endothelial cells have
completed their polarization process, exhibiting an apical
(luminal) and a basolateral domain. In this stage of capillary
development, a BM can be detected (Fig. 4H, magnified inset).
Finally, the initially solid cell cords have developed a central
lumen (Fig. 4I). At this stage the cytoplasm and the nuclei
become gradually more associated with the outer, basolateral
plasma membrane.
The scheme shown in Figure 5 is based on our electron
microscope (EM) data and light microscopical observations
and depicts the distinct steps of lumen formation. Notably,
the mechanism described here is in line with the cord hol-
lowing mode, which implies that a lumen is created de novo
in the intercellular space between polarizing cells within a
cylindrical cord.16
Engineered vascular structures are stabilized in vivo
To assess the therapeutic potential of our approach, we
analyzed integration, stabilization, and survival of the
transplants in animal studies. Prevascularized matrices were
grafted onto full-thickness skin wounds of 2.6 cm diameter
on 8–10 weeks old immunoincompetent Nu=Nu rats in six
independent sets of experiments.
Three types of grafts were analyzed: (1) gels without cells,
(2) gels containing single, randomly distributed HuMECs,
and (3) gels in which HuMECs had developed into lumenized
capillaries. We wanted to investigate whether the presence of
single ECs already had an effect on the vascularization of the
gels after transplantation (as compared to acellular gels). In
addition we decided to study whether there was a difference
in vascularization between prevascularized gels that may
rapidly connect to the underlying vascular network and gels
containing randomly distributed HuMECs (but no preformed
capillaries) that had no chance to rapidly connect to under-
lying vascular structures of the recipient animal.
Hematoxylin and eosin staining revealed the thickness and
structure of the fibrin gel that did not contain cells before
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FIG. 4. EM analyses reveal the critical implication of cell–cell and cell–matrix adhesion in the establishment of cell polar-
ization and intercellular lumen formation after submersion in a fibrin gel. (A) HuMECs for 2 days in a fibrin matrix. A
basement membrane (BM) cannot be recognized yet. (B) Seven days after plating, a BM starts to be deposited, and invag-
inating vesicles (white arrows) are visible. (C) Numerous invaginating vesicles (white arrows) indicate extensive pinocytosis
(cell drinking) 10 days after plating. Deposition of a BM is almost completed. Vacuoles (filled gray arrows) develop in the
cytoplasm. (D–G) Cross section through a capillary that has developed in a fibrin hydrogel within 15 days. (D) Laminin 1þ 2
staining reveals the deposition of a BM. (E) CD31 immunofluorescence. (F) Nuclear Hoechst staining. (G) Merger of (D–F).
(H) The polarized apical domains (AD) of three individual cells line the lumen (L) that develops in the intercellular space.
Lumen-forming HuMECs contain several vacuoles (v). The lumen is always free of extracellular material. The basal domain
(BD) of the cells faces the extracellular matrix of the hydrogel. No mesenchymal cells can be detected. A BM (black arrow) is
deposited, see magnified inset. (I) A completely lumenized vascular structure is evident (indicated by the dotted line). The
nucleus still protrudes into the capillary lumen. At a later stage of capillary development, the nucleus will completely retract
to the capillary plasma membrane. Scale bars 10 mm. Color images available online at www.liebertonline.com=ten.
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FIG. 5. A model based on
our findings depicting the
distinct steps of endothelial
lumen formation in our
in vitro system. Our observa-
tions greatly favor the cord-
hollowing hypothesis: (1)
Aggregation of single ECs
into solid cords is mediated
by junctional complexes.
Contact with the extracellular
matrix determines the baso-
lateral membrane domain. (2)
An ‘‘early’’ BM is deposited.
The beginning pinocytotic
activity (vesicle invagina-
tions) results in the formation
of intracellular vacuoles that
are lined by the prospective
apical membrane (black dot-
ted line) or by the (final) api-
cal membrane (red dotted
line). (3) A lumen is created de
novo in the intercellular space
of polarizing ECs. Pinocytosis
is fully active. The BM is fur-
ther completed. (4) Vacuole
fusion results in the formation
of the lumen in the intercel-
lular space of two ECs. En-
dothelial cell polarity is fully
established. Color images
available online at www.
liebertonline.com=ten.
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transplantation (Fig. 6A). The adjacent rat mesenchyme
seemed to be unresponsive to the transplant, exhibiting only a
moderate cellularity (Fig. 6A). However, already 5 days after
transplantation, about one-third of the initially acellular gels
was populated by cells derived from the underlying rat tissue
(Fig. 6B). No vascular structures were detectable in these gels
at this stage. Interestingly, gels containing the randomly dis-
tributed single HuMECs induced cell accumulation in the
underlying rat mesenchyme (Fig. 6C). However, differenti-
ated vWf-positive vascular structures were not detected in
these gels (Fig. 6D). In contrast, prevascularized gels were
densely populated by cells. They were in close contact with a
dense, vascularized dermal mesenchyme (Fig. 6E). The
thickness of the gels after transplantation adapted to about
150–200 mm. There was dehydration of the gels followed by
degradation of fibrin and deposition of dermal matrix com-
ponents, as soon as fibroblasts of the recipient animal popu-
lated the gels (data not shown).
As expected, prevascularized grafts exhibited numerous
vWf-positive vascular structures (Fig. 6F). At 2 weeks after
transplantation, gels containing single HuMECs showed
only few vascular structures of rat origin. These had just
started to penetrate into the fibrin matrix (neovasculariza-
tion) (Fig. 6G). In contrast, the prevascularized gels had al-
ready long developed more differentiated vessels within the
transplanted (engineered) area (Fig. 6H).
The human origin of vessels in 19 days old prevascularized
transplantswas confirmedusing a primate-specificAlu probe.
In Figure 7A it is confirmed that the Alu probe binds to nuclei
of human cells, but does not hybridize to rat DNA (data not
shown). Similarly an antibody to human CD31 (anti-human
PECAM) made engineered capillaries of human origin visible
(Fig. 7B). Costaining of human CD31 and a smooth muscle
a-actin–specific antibody showed that most of the trans-
planted human capillaries were stabilized by a-actin–positive
mural cells. (Fig. 7C). The antibody directed to smoothmuscle
a-actin was not rat specific, it also recognized the human
protein. However, these mural cells were most likely of rat
origin, sincemural cells were neither detectable on cell culture
plastic during the expansion phase nor could they be recog-
nized on engineered capillaries in vitro. This mechanism of
capillary stabilization may regulate the density of vascular
structures in a given developing or regenerating tissue.
Discussion
Successful transplantation of engineered tissues vitally
depends on rapid and adequate blood supply. Our goal was
to produce a prevascularized tissue substitute suitable for
transplantation. In particular we aimed at providing the graft
with a functioning capillary network that rapidly connects to
the recipient’s vascular system and thus allows timely per-
fusion and graft survival.
We show here that a network of branching and continu-
ously lumenized capillaries can be produced in vitro and that
prevascularization of tissue substitutes (derived from fibrin
hydrogels) is demanding but possible. Fibrin has been
demonstrated to be angiogenic in vivo and to support an-
giogenesis in 3D models in vitro.17–19 In contrast, more light
has to be shed on the vasculogenic properties of fibrin in vitro.
Evidence for tube formation in fibrin is very limited.20–22
We show here that simple capillaries can develop in fibrin-
based hydrogels from single dermal endothelial cells. En-
dothelial cells arrange into networks of lumenized capillaries
within 15 to 21 days. The great number of capillaries may
perhaps develop just by proliferation and differentiation of
committed (nonprecursor) endothelial cells that remain
functional for an extended period of time. In this case these
structures would not self-renew and thus disappear with
time. We therefore consider it much more likely that endo-
thelial progenitor cells (EPCs), present in our initial cell
preparations, give rise to de novo developing vascular struc-
tures. With the described culture system in our hands, we are
now in the position to determine from which tissue source
the EPCs are derived.
Based on the consideration that single EPCs may give rise
to the genesis of new capillaries, one may argue that the
process of capillary formation in vitro shows typical charac-
teristics of vasculogenesis. Thus, in accordance to the reports
from other investigators who looked into neovasculariza-
tion,23–26 our findings suggest that the genesis of new blood
vessels in vitro may not be restricted to angiogenesis, but
may also involve vasculogenesis.
The transparency of the hydrogels used in our experiments
allowed documentation of the distinct steps of capillary
formation. To our knowledge documentation of the genesis
of capillaries has rarely been shown before in this clarity and
FIG. 6. Transplantation of three different types of hydrogels onto immunoincompetent rats: (1) gels without HuMECs, (2)
gels with single, unorganized HuMECs, (3) prevascularized gels (A–F). Gels, 5 days after transplantation. (A) HE staining
reveals the thickness and structure of the fibrin gel that did not contain cells before transplantation. The lower edge of the gel
is marked by a white dotted line. The underlying mesenchyme seems to be unresponsive to the transplant, exhibiting only
moderate cellularity. (B) Hoechst staining of a parallel section of the gel shown in (A) uncovers that the lower one-third of the
gel is populated by rat cells, derived from the wound bed. The surface of the gel is apparently covered by a layer of rat cells
that were contained in the wound fluid contacting the surface of the gel after its transplantation. No angiogenic structures are
detected yet in these gels, using an antibody to von Willebrand factor (vWF). (C) Gels containing randomly distributed single
HuMECs are thicker and obviously induce the underlying rat mesenchyme 5 days after transplantation. (D) However,
differentiated vWf-positive angiogenic structures cannot be detected yet in the transplanted hydrogels. In a few spots
endothelial cells have arranged into aggregates. (E) The prevascularized gel is about 200m thick. As expected, it exhibits a
high degree of cellularity. It obviously induces a dense dermal mesenchyme. (F) Prevascularized grafts exhibit numerous
vWF-positive vessels in the engineered part. (G, H) Gels 2 weeks after transplantation. (G) Gels containing single unorga-
nized HuMECs show only few blood vessels of rat origin that are just entering the transplanted fibrin matrix (neovascu-
larization), as revealed by the use of laminin 1þ 2 specific antibodies. (H) In contrast, prevascularized gels contain vessels of
progressed differentiation throughout the transplanted graft. All scale bars 50mm. Color images available online at
www.liebertonline.com=ten.
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quality. Our light and electron microscopical data show that
two developmental steps are absolutely required to bring
aboutcapillary formation.Theseare the invaginationofvesicles
from the plasma membrane, referred to as pinocytosis and
the deposition of a BM. Pinocytosis of membrane-bounded
(bounded is bordered) vesicles appears to be an early step in
capillary lumen formation. These vesicles coalesce to form a
large vacuole within the intercellular space that fuses with the
vacuoles of neighboring cells to establish luminal continuity.
If this model of vascular tube formation is correct, then for-
mation and targeting of apical membrane vesicles lie at the
heart of the mechanism of tube formation. A prerequisite for
that is the deposition of a uniform circumferential BM, which
crucially guides the establishment of a radial polarity axis and
finally stabilizes the growing microvessel.27,28
In its simplest manner, vascular development involves the
following processes: formation, branching, sprouting, stabi-
lization, remodeling and pruning, and specialization. We
show here that capillary formation, branching, and sprouting
can be achieved in vitro. We demonstrate that the timing of
these processes overlaps.
We have developed a technique to facilitate endothelial
cell extraction from dermal microvasculature. Fibroblasts
contaminated our endothelial cell cultures in low numbers (if
at all). Thus, in contrast to reports on the formation of vas-
cular structures by HUVECs that require supporting fibro-
blasts and keratinocytes,12,29 we show that human capillaries
derived from dermal HuMECs can form and differentiate
in vitro without the support of mural cells (pericytes, smooth
muscle cells) or any other cell type. It remains to be inves-
tigated whether the two distinct sources of ECs are relevant
in this respect.
After transplantation, the differentiation process of the
in vitro generated vascular structures continues by the at-
FIG. 7. Engineered human capillaries are stabilized by mural cells of rat origin. (A) The human origin of the vessels in the
prevascularized transplants is confirmed by in situ hybridization using a DNA probe that specifically recognizes primate-
specific Alu sequences. The figure shows four nuclei of human origin in a histological section through one fully lumenized
capillary that developed within 19 days in the hydrogel. The lumen is indicated by gray arrows. Black arrows point to the
plasma membrane. (B) Similarly an antibody to human CD31 (anti-human PECAM) reveals engineered capillaries of human
origin (red fluorescence) 20 days after transplantation of the prevascularized graft onto a rat wound. (C) Costaining of
human CD31 and rat smooth muscle a-actin 20 days after transplantation shows that most of the transplanted vessels of
human origin are stabilized by a-actin–positive mural cells, such as pericytes and vascular smooth muscle cells. Smooth
muscle a-actin-positive cells are most likely of rat origin, since they were extremely rare and could not be maintained in our
EC cultures. Scale bar in (A) 10 mm, and in (B) and (C) 50mm. Color images available online at www.liebertonline.com=ten.
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traction of mural cells, which are known to support stabili-
zation and maturation of capillaries.28,30 The developing
capillary network extends throughout the thickness of the
hydrogel.
We found repeatedly that there is rapid vascularization
after prevascularized matrices were transplanted onto im-
munoincompetent rats. However, the exact mechanism of
inosculation, and of the interaction of vessels of the wound
bed of the recipient animal with preformed vessels in the
transplant, still remains to be worked on in more detail.
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